Cochrane Abstracts
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ganoderma Lucidum Mushroom for the Treatment of Cardiovascular Risk Factors." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438386/all/Ganoderma_lucidum_mushroom_for_the_treatment_of_cardiovascular_risk_factors.
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/all/Ganoderma_lucidum_mushroom_for_the_treatment_of_cardiovascular_risk_factors. Accessed January 24, 2025.
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/all/Ganoderma_lucidum_mushroom_for_the_treatment_of_cardiovascular_risk_factors
Ganoderma Lucidum Mushroom for the Treatment of Cardiovascular Risk Factors [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/all/Ganoderma_lucidum_mushroom_for_the_treatment_of_cardiovascular_risk_factors.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
ID - 438386
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/all/Ganoderma_lucidum_mushroom_for_the_treatment_of_cardiovascular_risk_factors
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
